DOJ Fights Walmart's Opioid Challenge At 5th Circ.

By Adam Lidgett · July 26, 2021, 3:56 PM EDT

The U.S. Department of Justice said Friday the Fifth Circuit should reject Walmart's bid to resurrect a suit where the retail giant sought a declaration that its prescription opioid sales are...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

2890 Other Statutory Actions

Date Filed

March 10, 2021

Recent Articles By Adam

July 11, 2024
Senate Clears Patent Bill Aiming To Lower Drug Prices
June 07, 2024
DC Circ. Undoes Library Of Congress Win In Fair Use Fight
June 06, 2024
8th Circ. Affirms Cigna Noncompete Applies To CVS Hire
May 29, 2024
Greenberg Traurig Adds IP Atty From Eversheds Sutherland
May 20, 2024
Judge Tosses Acuitas' COVID Biotech IP Suit
April 30, 2024
FTC Continues To Target 'Junk' Drug Patents
April 10, 2024
Pharmacy Gets Eli Lilly's Mounjaro Suit Tossed
April 09, 2024
Endo Sues FDA Over Generic Adrenalin Approvals
March 25, 2024
Vidal Vacates Denials Of Challenges To Neo Wireless IP
March 21, 2024
Business Coalition Rebuffs Biden Plan To Seize Drug Patents